title: Successful management of chronic myeloid leukemia with a complication of anti-SRP antibody-associated myopathy.
authors.affiliation: a Department of Hematology and Oncology, Graduate School of Medicine , The University of Tokyo , Tokyo , Japan.
authors.forename: Kiyomi
authors.initials: K
authors.lastname: Morita
authors.affiliation: a Department of Hematology and Oncology, Graduate School of Medicine , The University of Tokyo , Tokyo , Japan.
authors.forename: Fumihiko
authors.initials: F
authors.lastname: Nakamura
authors.affiliation: b Department of Neurology, Graduate School of Medicine , The University of Tokyo , Tokyo , Japan.
authors.forename: Kaori
authors.initials: K
authors.lastname: Sakuishi
authors.affiliation: b Department of Neurology, Graduate School of Medicine , The University of Tokyo , Tokyo , Japan.
authors.forename: Tomotaka
authors.initials: T
authors.lastname: Yamamoto
authors.affiliation: b Department of Neurology, Graduate School of Medicine , The University of Tokyo , Tokyo , Japan.
authors.forename: Jun
authors.initials: J
authors.lastname: Shimizu
authors.affiliation: b Department of Neurology, Graduate School of Medicine , The University of Tokyo , Tokyo , Japan.
authors.forename: Shoji
authors.initials: S
authors.lastname: Tsuji
authors.affiliation: a Department of Hematology and Oncology, Graduate School of Medicine , The University of Tokyo , Tokyo , Japan.
authors.forename: Mineo
authors.initials: M
authors.lastname: Kurokawa
mesh_terms: D001323:Autoantibodies / Q000276:immunology*; D001324:Autoantigens / Q000276:immunology*; D015415:Biomarkers; D019468:Disease Management; D006801:Humans; D000068877:Imatinib Mesylate / Q000009:adverse effects / Q000627:therapeutic use; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000175:diagnosis* / Q000209:etiology* / Q000628:therapy; D018271:Signal Recognition Particle / Q000276:immunology*; D016896:Treatment Outcome
chemical_list: D001323:Autoantibodies; D001324:Autoantigens; D015415:Biomarkers; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D018271:Signal Recognition Particle; D000068877:Imatinib Mesylate